Expert Interviews
Expert Interviews
Hans Hammers, MD, PhDRenal Cell Carcinoma | September 8, 2023
Dr. Hammers discusses the kidney clinical trials he has led and shares his perspectives on novel IO and targeted therapies.
Read More
Guru P. Sonpavde, MDMuscle Invasive Urothelial Carcinoma | August 24, 2023
Dr. Sonpavde expounds on the current state and momentum of research efforts to advance treatment strategies in MIBC.
Arlene O. Siefker-Radtke, MDAdvanced Urothelial Carcinoma | May 26, 2023
Dr. Siefker-Radtke shares the novel targeted therapies for bladder cancer and how they are assessed in combinations.
Pavlos Msaouel, MD, PhDRenal Cell Carcinoma | May 18, 2023
Dr. Msaouel shares his journey to becoming a world expert in RMC and the clinical trial work he led to improve outcomes.
Katherine Virgo, PhD, MBAExpert Interviews | May 2, 2023
Katherine Virgo, PhD, MBA, provided insight into ASCO's updated guideline for the management of metastatic prostate cancer.
David Ambinder, MDProstate Cancer | March 31, 2023
Michigan Urological Surgery and Improvement Collaborative is an effort to improve patient lives through high-quality care.
Emily MenendezExpert Interviews | March 30, 2023
A recent study examined safety and efficacy from the ARASENS trial for certain subgroups by disease volume and risk.
A. Ari Hakimi, MDAdvanced Renal Cell Carcinoma | March 28, 2023
Dr. A. Ari Hakimi discusses how cytoreductive nephrectomy has evolved and is being used in today’s mRCC treatment paradigm.
Preston Sprenkle, MDProstate Cancer | March 24, 2023
Dr. Sprenkle shares his inspiration to practice urologic oncology and his role in popularizing the Artemis Device.
Vignesh Packiam, MDNon-Muscle Invasive Urothelial Carcinoma | March 22, 2023
Vignesh T. Packiam, MD discusses the current BCG shortage as well as potential substitutes such as gemcitabine and docetaxel.
Sangeeta Goswami, MD, PhDUrothelial Carcinoma | March 21, 2023
Dr. Goswami discusses the trials that are changing our understanding of resistance to ICIs in kidney and bladder cancer.
Akhil Abraham Saji, MDProstate Cancer | March 10, 2023
Mutahar Ahmed, MD, discusses the history and current applications of single-port robotic surgery in prostate cancer.
Pavlos Msaouel, MD, PhDRenal Cell Carcinoma | March 10, 2023
Dr. Msaouel provides an overview of the molecular characteristics and treatment for nccRCC, with a particular focus on RMC.
Rachelle Rodriguez, MS, APRN, AOCNPExpert Interviews | March 6, 2023
Rachelle Rodriguez, MS, APRN, AOCNP, highlights her role in helping Moffitt grow its APP presence within the GU onc program.
David Braun, MD, PhDAdvanced Renal Cell Carcinoma | February 14, 2023
David Braun, MD, PhD, highlights the available later-line therapy options for RCC, how the therapies are sequenced, and more.
Rishabh Simhal, MDExpert Interviews | February 10, 2023
Rishabh Simhal, MD, discusses baseline fatigue and OS in patients with prostate cancer, as well as the FACIT-F questionnaire.
Yair Lotan, MDUpper Tract Urothelial Carcinoma | February 10, 2023
Yair Lotan, MD, details the real-world use, effectiveness, and standard-of-care potential of UGN-101 for patients with UTUC.
Alex Pozdnyakov, MDNext-Generation Imaging | February 8, 2023
Alex Pozdnyakov, MD, explains the current utility and potential application of PSMA PET imaging in prostate cancer.
Jonathan Coleman, MDUpper Tract Urothelial Carcinoma | February 7, 2023
Dr. Coleman shares his unique career path, his role in defining UTUC, and ongoing research to improve patient outcomes.
Joshua Meeks, MD, PhDNon-Muscle Invasive Urothelial Carcinoma | January 27, 2023
Joshua Meeks, MD, PhD, discusses ongoing research in NMIBC and the future of urothelial carcinoma care.